Ordinary Adjustment | Solactive Healthcare Index | Effective Date 8th April 2026

March 25, 2026

Announcement

Ordinary Adjustment | Solactive Healthcare Index | Effective Date 8th April 2026

Solactive Healthcare Index:

In the ordinary adjustment, the following composition will be implemented effective open 8th April 2026:

ABBOTT LABORATORIES
ABBVIE INC
AGILENT TECHNOLOGIES INC
ALCON INC
ALNYLAM PHARMACEUTICALS INC
AMGEN INC
ARGENX SE - ADR
ASTRAZENECA PLC
BECTON DICKINSON AND CO
BOSTON SCIENTIFIC CORP
BRISTOL-MYERS SQUIBB CO
CHUGAI PHARMACEUTICAL CO LTD ORD
CIGNA GROUP
CSL LTD ORD
DAIICHI SANKYO CO LTD ORD
DANAHER CORP
EDWARDS LIFESCIENCES CORP
ELEVANCE HEALTH INC
ELI LILLY & CO
ESSILORLUXOTTICA
GE HEALTHCARE TECHNOLOGIES INC
GILEAD SCIENCES INC
GSK PLC
HALEON PLC
HCA HEALTHCARE INC
HOYA CORP ORD
IDEXX LABORATORIES INC
INSMED INC
INTUITIVE SURGICAL INC
JOHNSON & JOHNSON
LONZA GROUP AG
MEDTRONIC PLC
MERCK & CO. INC.
NOVARTIS AG
NOVO NORDISK A/S
OTSUKA HOLDINGS CO LTD ORD
PFIZER INC
REGENERON PHARMACEUTICALS
RESMED INC
ROCHE HOLDING AG
SANDOZ GROUP AG
SANOFI SA
STRYKER CORP
TAKEDA PHARMACEUTICAL
THERMO FISHER SCIENTIFIC INC
UCB SA
UNITEDHEALTH GROUP INC
VERTEX PHARMACEUTICALS INC
WATERS CORP
ZOETIS INC

Share your view and thoughts

We work closely with our internal partners to deliver investment ideas that generate demonstrable value for our clients.